Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase.

Westwood JP, Scully M

Open source

DOI
10.1177/20406207221112217
Published
2022
Container
Therapeutic advances in hematology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20406207221112217,
  title = {Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase.},
  author = {Westwood JP and Scully M},
  year = {2022},
  journal = {Therapeutic advances in hematology},
  doi = {10.1177/20406207221112217},
  url = {https://doi.org/10.1177/20406207221112217}
}

RIS

TY  - JOUR
TI  - Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase.
AU  - Westwood JP
AU  - Scully M
PY  - 2022
JO  - Therapeutic advances in hematology
DO  - 10.1177/20406207221112217
UR  - https://doi.org/10.1177/20406207221112217
ER  - 

APA

JP, W., & M, S. (2022). Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase.. Therapeutic advances in hematology. https://doi.org/10.1177/20406207221112217

Source records